Announcements

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

PCPC
Jul 31, 2019
1 min read

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.

View Full Article

Recent Posts

See All

UVic-PC releases more assays on the CPTAC Assay portal

CPTAC and researchers from the University of Victoria – Genome British Columbia Proteomics Centre just released over 130 quantitative,...

UVic upgrades Agilent QqQ's

In partnership with Agilent, we have upgraded 2 of our 6490 triple quadrupole mass spectrometers the the latest 6495b platforms. These...

Come check us out at ASMS in Atlanta

Members of the PCPC have 13 posters and 5 oral presentations at ASMS 2019! See you there!!! #ASMS2019

Announcements

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

Recent Posts

Comments

Our Funding Partners